This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning technology / solutions within the healthcare industry. An elaborate valuation analysis of companies that are involved in the deep learning in drug discovery and diagnostics market, based on our proprietary, multi-variable dependent valuation model to estimate the current valuation / net worth of deep learning industry players.
The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:
- Therapeutic Area
- Oncological Disorders
- Infectious Diseases
- Neurological Disorders
- Immunological Disorders
- Endocrine Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Ophthalmic Disorders
- Musculoskeletal Disorders
- Inflammatory Disorders
- Other Disorders
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Rest of the World
The Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
- Aegicare
- Aiforia Technologies
- Ardigen
- Berg
- Huawei
- Merative
- Nference
- NVIDIA
- Owkin
- Phenomic AI
- Pixel AI
Table of Contents
- PREFACE
- EXECUTIVE SUMMARY
- INTRODUCTION
- MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY
- MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS
- COMPANY PROFILES
- PORTER’S FIVE FORCES ANALYSIS
- CLINICAL TRIAL ANALYSIS
- FUNDING AND INVESTMENT ANALYSIS
- START-UP HEALTH INDEXING
- COMPANY VALUATION ANALYSIS
- MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY
- MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS
- DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS
- CONCLUDING REMARKS
- INTERVIEW TRANSCRIPTS
- APPENDIX 1: TABULATED DATA
- APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html
Learn from experts: do you know about these emerging industry trends?
Key Trends in Non-Viral Transfection Market
Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
